Quick Answer
Alpha Tau Medical Ltd. reported R&D Expense of $32.06 million for fiscal year 2025.
Alpha Tau Medical Ltd. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $32.06M | +18.7% |
| 2024 | $27.02M | +2.3% |
| 2023 | $26.42M | +26.5% |
| 2022 | $20.89M | +82.5% |
| 2021 | $11.45M | +51.7% |
| 2020 | $7.54M | +13.7% |
| 2019 | $6.64M | — |
- Alpha Tau Medical Ltd. showed an increase of +18.7% in R&D Expense compared to the prior fiscal year.
- Over the 2019–2025 period, Alpha Tau Medical Ltd.’s r&d expense has grown by 383.2% (from $6.64 million to $32.06 million).
- The most recent figure is from Alpha Tau Medical Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: